Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor X”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)Ended earlyNCT04233073
What this trial is testing

Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery

Who this might be right for
Surgery
Alexion Pharmaceuticals, Inc. 10
Not applicableStudy completedNCT02971969
What this trial is testing

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Testing effectiveness (Phase 2)Study completedNCT03995784
What this trial is testing

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Catalyst Biosciences 6
Large-scale testing (Phase 3)Study completedNCT02053792
What this trial is testing

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 97
Not applicableStudy completedNCT05217992
What this trial is testing

Are There Differences Between Carriers of Haemophilia A and B?

Who this might be right for
Hemophilia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 900
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Testing effectiveness (Phase 2)Active Not RecruitingNCT01687608
What this trial is testing

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Very early researchWithdrawnNCT03921515
What this trial is testing

Skin Immunity Sample Collection Involving Blisters and Biopsies

Who this might be right for
Hyper-Immunoglobulin E. Syndrome (HEIS)Chronic Granulomatous Disease (CGD)
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01207908
What this trial is testing

Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Children's Hospital Medical Center, Cincinnati 44
Large-scale testing (Phase 3)Study completedNCT01625390
What this trial is testing

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Who this might be right for
Hemophilia A, Hemophilia B
Bayer 10
Large-scale testing (Phase 3)Active Not RecruitingNCT03861273
What this trial is testing

Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 51
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT00464477
What this trial is testing

Advanced Grandparental Age as a Risk Factor for Autism

Who this might be right for
Autistic DisorderPervasive Developmental DisorderAsperger Syndrome+2 more
University of Mississippi Medical Center 100
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Not applicableStudy completedNCT00001414
What this trial is testing

Mapping Personality Traits to Genes

Who this might be right for
Mental Disorder
National Institute of Mental Health (NIMH) 2,400
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT00076557
What this trial is testing

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Who this might be right for
Hemophilia B
Avigen 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Large-scale testing (Phase 3)Ended earlyNCT01271868
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 9
Not applicableStudy completedNCT01661010
What this trial is testing

The Clinical Study of Sex Chromosome Variants

Who this might be right for
Male Factor InfertilityFemale Factor Infertility
National Human Genome Research Institute (NHGRI) 112
Load More Results